Roanoke Asset Management Corp Eli Lilly & CO Transaction History

Roanoke Asset Management Corp

$311 Million
Q4 2024

A detailed history of Roanoke Asset Management Corp transactions in Eli Lilly & CO stock. As of the latest transaction made, Roanoke Asset Management Corp holds 12,567 shares of LLY stock, worth $11.6 Million. This represents 3.12% of its overall portfolio holdings.

Number of Shares

12,567

Previous 12,237 2.7%

Holding current value

$11.6 Million

Previous $10.8 Million 10.52%

% of portfolio

3.12%

Previous 3.41%

28 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 05, 2025	BUY	$727.2 - $932.06 $239,976 - $307,579	330 Added 2.7%	12,567 $9.7 Million
Q3 2024 Oct 28, 2024	SELL	$772.14 - $960.02 $34,746 - $43,200	-45 Reduced 0.37%	12,237 $10.8 Million
Q2 2024 Aug 14, 2024	SELL	$724.87 - $909.04 $658,181 - $825,408	-908 Reduced 6.88%	12,282 $11.1 Million
Q1 2024 May 08, 2024	SELL	$592.2 - $792.28 $8,883 - $11,884	-15 Reduced 0.11%	13,190 $10.3 Million
Q4 2023 Feb 08, 2024	SELL	$525.19 - $619.13 $152,305 - $179,547	-290 Reduced 2.15%	13,205 $7.7 Million
Q3 2023 Nov 15, 2023	SELL	$434.7 - $599.3 $878,094 - $1.21 Million	-2,020 Reduced 13.02%	13,495 $7.25 Million
Q2 2023 Jul 31, 2023	SELL	$350.74 - $468.98 $17,537 - $23,449	-50 Reduced 0.32%	15,515 $7.28 Million
Q1 2023 May 02, 2023	SELL	$310.63 - $364.82 $3,106 - $3,648	-10 Reduced 0.06%	15,565 $5.35 Million
Q4 2022 Feb 08, 2023	SELL	$321.55 - $374.67 $334,412 - $389,656	-1,040 Reduced 6.26%	15,575 $5.7 Million
Q2 2022 Aug 10, 2022	SELL	$278.73 - $327.27 $770,688 - $904,901	-2,765 Reduced 14.27%	16,615 $5.39 Million
Q1 2022 May 11, 2022	SELL	$234.69 - $291.66 $408,360 - $507,488	-1,740 Reduced 8.24%	19,380 $5.55 Million
Q4 2021 Feb 09, 2022	SELL	$224.85 - $279.04 $104,330 - $129,474	-464 Reduced 2.15%	21,120 $5.83 Million
Q3 2021 Nov 03, 2021	SELL	$221.6 - $272.71 $24,376 - $29,998	-110 Reduced 0.51%	21,584 $4.99 Million
Q2 2021 Jul 28, 2021	BUY	$180.55 - $233.54 $852,196 - $1.1 Million	4,720 Added 27.81%	21,694 $4.98 Million
Q1 2021 May 14, 2021	SELL	$164.32 - $212.72 $3,286 - $4,254	-20 Reduced 0.12%	16,974 $3.17 Million
Q4 2020 Feb 12, 2021	SELL	$130.46 - $172.63 $31,310 - $41,431	-240 Reduced 1.39%	16,994 $2.87 Million
Q3 2020 Nov 12, 2020	SELL	$146.22 - $169.13 $285,860 - $330,649	-1,955 Reduced 10.19%	17,234 $2.55 Million
Q2 2020 Aug 05, 2020	SELL	$136.42 - $164.18 $369,971 - $445,256	-2,712 Reduced 12.38%	19,189 $3.15 Million
Q1 2020 May 13, 2020	SELL	$119.05 - $147.35 $14,881 - $18,418	-125 Reduced 0.57%	21,901 $3.04 Million
Q4 2019 Feb 05, 2020	SELL	$106.92 - $132.43 $565,927 - $700,951	-5,293 Reduced 19.37%	22,026 $2.9 Million
Q3 2019 Nov 01, 2019	SELL	$106.79 - $116.16 $87,567 - $95,251	-820 Reduced 2.91%	27,319 $3.06 Million
Q2 2019 Jul 19, 2019	SELL	$110.79 - $129.32 $24,373 - $28,450	-220 Reduced 0.78%	28,139 $3.12 Million
Q4 2018 Feb 06, 2019	SELL	$105.9 - $118.64 $40,771 - $45,676	-385 Reduced 1.34%	28,359 $3.28 Million
Q3 2018 Oct 30, 2018	SELL	$85.86 - $107.31 $1,287 - $1,609	-15 Reduced 0.05%	28,744 $3.08 Million
Q2 2018 Jul 25, 2018	SELL	$75.7 - $86.88 $130,279 - $149,520	-1,721 Reduced 5.65%	28,759 $2.45 Million
Q1 2018 Apr 19, 2018	SELL	$74.21 - $87.6 $69,386 - $81,906	-935 Reduced 2.98%	30,480 $2.36 Million
Q4 2017 Jan 29, 2018	SELL	$81.94 - $87.89 $439,198 - $471,090	-5,360 Reduced 14.58%	31,415 $2.65 Million
Q3 2017 Oct 20, 2017	BUY	$77.07 - $85.54 $2.83 Million - $3.15 Million	36,775	36,775 $3.15 Million

Others Institutions Holding LLY

# of Institutions

4,278

Shares Held

757M

Call Options Held

10.2M

Put Options Held

11.4M

View Full List

About ELI LILLY & Co

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $875B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

More about LLY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Roanoke Asset Management Corp, based on Form 13F filings with the SEC.

News

Stay updated on Roanoke Asset Management Corp with notifications on news.

Account

Roanoke Asset Management Corp Eli Lilly & CO Transaction History